Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.

Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.

Pyronaridine-artesunate is a newly introduced artemisinin-based combination treatment which may be deployed together with primaquine. A single-dose, randomized, three-sequence crossover study was conducted in healthy Thai volunteers to characterize potential pharmacokinetic interactions between thes...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jittamala, P, Pukrittayakamee, S, Ashley, E, Nosten, F, Hanboonkunupakarn, B, Lee, S, Thana, P, Chairat, K, Blessborn, D, Panapipat, S, White, N, Day, N, Tarning, J
Format:	Journal article
Idioma:	English
Publicat:	American Society for Microbiology 2015

Ítems similars

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
per: Hanboonkunupakarn, B, et al.
Publicat: (2014)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
per: Chairat, K, et al.
Publicat: (2018)

Pharmacokinetic interactions between primaquine and chloroquine.
per: Pukrittayakamee, S, et al.
Publicat: (2014)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
per: Tarning, J, et al.
Publicat: (2024)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
per: Joel Tarning, et al.
Publicat: (2024-10-01)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
per: Jittamala, P, et al.
Publicat: (2014)

Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects
per: Kobylinski, KC, et al.
Publicat: (2019)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
per: Jittamala, P, et al.
Publicat: (2014)

Pyronaridine-artesunate for uncomplicated falciparum malaria.
per: Nosten, F
Publicat: (2010)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
per: Chotsiri, P, et al.
Publicat: (2017)

Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
per: Rueangweerayut, R, et al.
Publicat: (2012)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
per: Chairat, K, et al.
Publicat: (2016)

Transmission-blocking activities of quinine, primaquine, and artesunate.
per: Chotivanich, K, et al.
Publicat: (2006)

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria.
per: Pukrittayakamee, S, et al.
Publicat: (2004)

Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS - increased sensitivity resulting from reduced non-specific binding
per: Blessborn, D, et al.
Publicat: (2017)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
per: Pukrittayakamee, S, et al.
Publicat: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
per: Pukrittayakamee, S, et al.
Publicat: (2011)

Sequential open-label study of the safety, tolerability, and pharmacokinetic interactions between dihydroartemisinin-piperaquine and mefloquine in healthy Thai adults
per: Hanboonkunupakarn, B, et al.
Publicat: (2019)

Application of Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung and Trachea Exposure of Pyronaridine and Artesunate in Hamsters
per: Dong Wook Kang, et al.
Publicat: (2023-03-01)

Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
per: Wattanakul, T, et al.
Publicat: (2024)

Primaquine pharmacokinetics in lactating women and breastfed infant exposures
per: Gilder, M, et al.
Publicat: (2018)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
per: Von Seidlein, L, et al.
Publicat: (2019)

Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
per: Thanaporn Wattanakul, et al.
Publicat: (2024-05-01)

Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria
per: Chu, C, et al.
Publicat: (2018)

Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria
per: Chu, C, et al.
Publicat: (2018)

Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
per: Chotsiri, P, et al.
Publicat: (2022)

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
per: Pukrittayakamee, S, et al.
Publicat: (2024)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
per: Johanna M. Roth, et al.
Publicat: (2018-06-01)

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
per: Kloprogge, F, et al.
Publicat: (2015)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
per: Lorenz von Seidlein, et al.
Publicat: (2020-01-01)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
per: Mcgready, R, et al.
Publicat: (2012)

Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia
per: Hussein Mohammed, et al.
Publicat: (2022-12-01)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
per: Tarning, J, et al.
Publicat: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
per: Tarning, J, et al.
Publicat: (2014)

Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects.
per: Ward, SA, et al.
Publicat: (1985)

Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa
per: Fanello, C, et al.
Publicat: (2021)

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
per: Sasithon Pukrittayakamee, et al.
Publicat: (2024-02-01)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
per: Jamsen, K, et al.
Publicat: (2011)

Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
per: Silachamroon, U, et al.
Publicat: (2003)

Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
per: Price, R, et al.
Publicat: (1999)